nach oben

Reactions Weekly

Erschienen in:

01.03.2019 | Case report

Fexofenadine

Various toxicities: 4 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

A prospective, observational study conducted between September 2015 and October 2017 described four patients (two boys and two girls) aged 2-6 years, who developed headache (1 patient), drowsiness (1 patient), otitis media with effusion, acute rhinosinusitis and influenza B infection (1 patient) or febrile convulsions (1 patient) during antihistamine therapy with fexofenadine [Allegra; route and times to reactions onsets not stated; not all outcomes stated]. …

Suzuki K. Safety and effectiveness of fexofenadine (5% dry syrup formulation; Allegra 5% Dry Syrup) in Japanese children with allergic rhinitis, urticaria and pruritus associated with skin diseases in practical setting. [Japanese]. Therapeutic Research 39: 1019-1033, No. 12, Jan 2018. Available from: URL: http://therres.jp/2TRcontents/2018/20181227142820.php [Japanese; summarised from atranslation] - Japan

Titel: Fexofenadine
Various toxicities: 4 case reports
Publikationsdatum: 01.03.2019
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-019-59292-6

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Fexofenadine

Various toxicities: 4 case reports

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2019

Alirocumab

Carbimazole

Iodine-125

Tocilizumab

Bupivacaine

Acetazolamide